403 related articles for article (PubMed ID: 25711636)
1. The Chemokine Platelet Factor-4 Variant (PF-4var)/CXCL4L1 Inhibits Diabetes-Induced Blood-Retinal Barrier Breakdown.
Abu El-Asrar AM; Mohammad G; Nawaz MI; Abdelsaid M; Siddiquei MM; Alam K; Van den Eynde K; De Hertogh G; Opdenakker G; Al-Shabrawey M; Van Damme J; Struyf S
Invest Ophthalmol Vis Sci; 2015 Feb; 56(3):1956-64. PubMed ID: 25711636
[TBL] [Abstract][Full Text] [Related]
2. Platelet factor-4 variant chemokine CXCL4L1 inhibits melanoma and lung carcinoma growth and metastasis by preventing angiogenesis.
Struyf S; Burdick MD; Peeters E; Van den Broeck K; Dillen C; Proost P; Van Damme J; Strieter RM
Cancer Res; 2007 Jun; 67(12):5940-8. PubMed ID: 17575164
[TBL] [Abstract][Full Text] [Related]
3. Cross-Talk between Sirtuin 1 and the Proinflammatory Mediator High-Mobility Group Box-1 in the Regulation of Blood-Retinal Barrier Breakdown in Diabetic Retinopathy.
Mohammad G; Abdelaziz GM; Siddiquei MM; Ahmad A; De Hertogh G; Abu El-Asrar AM
Curr Eye Res; 2019 Oct; 44(10):1133-1143. PubMed ID: 31136205
[No Abstract] [Full Text] [Related]
4. Α-Melanocyte-Stimulating Hormone Protects Early Diabetic Retina from Blood-Retinal Barrier Breakdown and Vascular Leakage via MC4R.
Cai S; Yang Q; Hou M; Han Q; Zhang H; Wang J; Qi C; Bo Q; Ru Y; Yang W; Gu Z; Wei R; Cao Y; Li X; Zhang Y
Cell Physiol Biochem; 2018; 45(2):505-522. PubMed ID: 29402864
[TBL] [Abstract][Full Text] [Related]
5. High-Mobility Group Box-1 Modulates the Expression of Inflammatory and Angiogenic Signaling Pathways in Diabetic Retina.
Abu El-Asrar AM; Mohammad G; Nawaz MI; Siddiquei MM
Curr Eye Res; 2015; 40(11):1141-52. PubMed ID: 25495026
[TBL] [Abstract][Full Text] [Related]
6. Autocrine CCL2, CXCL4, CXCL9 and CXCL10 signal in retinal endothelial cells and are enhanced in diabetic retinopathy.
Nawaz MI; Van Raemdonck K; Mohammad G; Kangave D; Van Damme J; Abu El-Asrar AM; Struyf S
Exp Eye Res; 2013 Apr; 109():67-76. PubMed ID: 23352833
[TBL] [Abstract][Full Text] [Related]
7. The COOH-terminal peptide of platelet factor-4 variant (CXCL4L1/PF-4var47-70) strongly inhibits angiogenesis and suppresses B16 melanoma growth in vivo.
Vandercappellen J; Liekens S; Bronckaers A; Noppen S; Ronsse I; Dillen C; Belleri M; Mitola S; Proost P; Presta M; Struyf S; Van Damme J
Mol Cancer Res; 2010 Mar; 8(3):322-34. PubMed ID: 20215425
[TBL] [Abstract][Full Text] [Related]
8. Osteoprotegerin Is a New Regulator of Inflammation and Angiogenesis in Proliferative Diabetic Retinopathy.
Abu El-Asrar AM; Struyf S; Mohammad G; Gouwy M; Rytinx P; Siddiquei MM; Hernández C; Alam K; Mousa A; De Hertogh G; Opdenakker G; Simó R
Invest Ophthalmol Vis Sci; 2017 Jun; 58(7):3189-3201. PubMed ID: 28654984
[TBL] [Abstract][Full Text] [Related]
9. Expression of angiostatic platelet factor-4var/CXCL4L1 counterbalances angiogenic impulses of vascular endothelial growth factor, interleukin-8/CXCL8, and stromal cell-derived factor 1/CXCL12 in esophageal and colorectal cancer.
Verbeke H; De Hertogh G; Li S; Vandercappellen J; Noppen S; Schutyser E; El-Asrar AA; Opdenakker G; Van Damme J; Geboes K; Struyf S
Hum Pathol; 2010 Jul; 41(7):990-1001. PubMed ID: 20334899
[TBL] [Abstract][Full Text] [Related]
10. Beneficial effects of the Src inhibitor, dasatinib, on breakdown of the blood-retinal barrier.
Kim SR; Suh W
Arch Pharm Res; 2017 Feb; 40(2):197-203. PubMed ID: 27988882
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of angiostatic platelet factor-4 variant (CXCL4L1/PF-4var) versus inhibition of angiogenic granulocyte chemotactic protein-2 (CXCL6/GCP-2) in normal and tumoral mesenchymal cells.
Vandercappellen J; Noppen S; Verbeke H; Put W; Conings R; Gouwy M; Schutyser E; Proost P; Sciot R; Geboes K; Opdenakker G; Van Damme J; Struyf S
J Leukoc Biol; 2007 Dec; 82(6):1519-30. PubMed ID: 17827342
[TBL] [Abstract][Full Text] [Related]
12. Association of 150-kDa oxygen-regulated protein with vascular endothelial growth factor in proliferative diabetic retinopathy.
Abu El-Asrar AM; Ahmad A; Alam K; Bittoun E; Siddiquei MM; Mohammad G; Mousa A; De Hertogh G; Opdenakker G
Acta Ophthalmol; 2018 Jun; 96(4):e460-e467. PubMed ID: 29098793
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of Thrombin/Matrix Metalloproteinase-1/Protease-Activated Receptor-1 Chain in Proliferative Diabetic Retinopathy.
Abu El-Asrar AM; Alam K; Nawaz MI; Mohammad G; Van den Eynde K; Siddiquei MM; Mousa A; De Hertogh G; Opdenakker G
Curr Eye Res; 2016 Dec; 41(12):1590-1600. PubMed ID: 27261371
[TBL] [Abstract][Full Text] [Related]
14. Erythropoietin maintains VE-cadherin expression and barrier function in experimental diabetic retinopathy via inhibiting VEGF/VEGFR2/Src signaling pathway.
Liu D; Xu H; Zhang C; Xie H; Yang Q; Li W; Tian H; Lu L; Xu JY; Xu G; Liu K; Sun X; Xu GT; Zhang J
Life Sci; 2020 Oct; 259():118273. PubMed ID: 32800831
[TBL] [Abstract][Full Text] [Related]
15. Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1alpha and VEGF.
Poulaki V; Qin W; Joussen AM; Hurlbut P; Wiegand SJ; Rudge J; Yancopoulos GD; Adamis AP
J Clin Invest; 2002 Mar; 109(6):805-15. PubMed ID: 11901189
[TBL] [Abstract][Full Text] [Related]
16. Mutual enhancement between high-mobility group box-1 and NADPH oxidase-derived reactive oxygen species mediates diabetes-induced upregulation of retinal apoptotic markers.
Mohammad G; Alam K; Nawaz MI; Siddiquei MM; Mousa A; Abu El-Asrar AM
J Physiol Biochem; 2015 Sep; 71(3):359-72. PubMed ID: 26040511
[TBL] [Abstract][Full Text] [Related]
17. VEGF164 is proinflammatory in the diabetic retina.
Ishida S; Usui T; Yamashiro K; Kaji Y; Ahmed E; Carrasquillo KG; Amano S; Hida T; Oguchi Y; Adamis AP
Invest Ophthalmol Vis Sci; 2003 May; 44(5):2155-62. PubMed ID: 12714656
[TBL] [Abstract][Full Text] [Related]
18. The cKit Inhibitor, Masitinib, Prevents Diabetes-Induced Retinal Vascular Leakage.
Kim SR; Im JE; Jeong JH; Kim JY; Kim JT; Woo SJ; Sung JH; Park SG; Suh W
Invest Ophthalmol Vis Sci; 2016 Mar; 57(3):1201-6. PubMed ID: 26978025
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal triamcinolone acetonide inhibits breakdown of the blood-retinal barrier through differential regulation of VEGF-A and its receptors in early diabetic rat retinas.
Zhang X; Bao S; Lai D; Rapkins RW; Gillies MC
Diabetes; 2008 Apr; 57(4):1026-33. PubMed ID: 18174522
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes.
El-Remessy AB; Al-Shabrawey M; Khalifa Y; Tsai NT; Caldwell RB; Liou GI
Am J Pathol; 2006 Jan; 168(1):235-44. PubMed ID: 16400026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]